{"groups":[{"description":"Phase I - Thalidomide Dose Level 600 mg","id":"FG000","title":"Phase I - Thalidomide Dose Level 600 mg"},{"description":"Phase I - Thalidomide Dose Level 800 mg","id":"FG001","title":"Phase I - Thalidomide Dose Level 800 mg"},{"description":"Phase I - Thalidomide Dose Level 1000 mg","id":"FG002","title":"Phase I - Thalidomide Dose Level 1000 mg"},{"description":"Phase 2 Thalidomide Dose Level 1000 mg","id":"FG003","title":"Phase 2"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"20"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"20"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}